Synsam Valuation
Is 9FZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 9FZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 9FZ (€3.43) is trading below our estimate of fair value (€12.07)
Significantly Below Fair Value: 9FZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 9FZ?
Key metric: As 9FZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 9FZ's PE Ratio? | |
|---|---|
| PE Ratio | 17.4x |
| Earnings | SEK 352.00m |
| Market Cap | SEK 6.13b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 7.7x |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does 9FZ's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 16.8x | ||
FIE Fielmann Group | 23.8x | 18.9% | €3.4b |
HBH HORNBACH Holding KGaA | 7.7x | 6.8% | €1.3b |
CEC Ceconomy | 10.8x | 22.4% | €1.5b |
HBM HORNBACH Baumarkt | 24.8x | n/a | €1.8b |
9FZ Synsam | 17.4x | 28.6% | €6.1b |
Price-To-Earnings vs Peers: 9FZ is expensive based on its Price-To-Earnings Ratio (17.4x) compared to the peer average (16.8x).
Price to Earnings Ratio vs Industry
How does 9FZ's PE Ratio compare vs other companies in the European Specialty Retail Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 9FZ is expensive based on its Price-To-Earnings Ratio (17.4x) compared to the European Specialty Retail industry average (16x).
Price to Earnings Ratio vs Fair Ratio
What is 9FZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17.4x |
| Fair PE Ratio | 13.5x |
Price-To-Earnings vs Fair Ratio: 9FZ is expensive based on its Price-To-Earnings Ratio (17.4x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.43 | €5.50 +60.7% | 2.2% | €5.59 | €5.33 | n/a | 3 |
| Nov ’25 | €4.05 | €5.65 +39.5% | 2.2% | €5.74 | €5.47 | n/a | 3 |
| Oct ’25 | €4.26 | €5.65 +32.8% | 2.2% | €5.74 | €5.47 | n/a | 3 |
| Sep ’25 | €4.10 | €5.73 +40.0% | 5.6% | €6.14 | €5.35 | n/a | 3 |
| Aug ’25 | €4.13 | €5.65 +36.9% | 5.6% | €6.06 | €5.28 | n/a | 3 |
| Jul ’25 | €4.38 | €5.72 +30.5% | 5.4% | €6.20 | €5.41 | n/a | 4 |
| Jun ’25 | €4.65 | €5.49 +18.1% | 6.9% | €6.03 | €5.00 | n/a | 4 |
| May ’25 | €4.29 | €5.40 +25.8% | 9.1% | €6.24 | €5.08 | n/a | 4 |
| Apr ’25 | €4.95 | €5.40 +9.1% | 9.1% | €6.24 | €5.08 | n/a | 4 |
| Mar ’25 | €4.97 | €5.23 +5.3% | 12.4% | €6.26 | €4.47 | n/a | 4 |
| Feb ’25 | €4.28 | €4.86 +13.6% | 19.4% | €6.24 | €3.66 | n/a | 4 |
| Jan ’25 | €3.92 | €4.86 +24.0% | 19.4% | €6.24 | €3.66 | n/a | 4 |
| Dec ’24 | €3.45 | €4.77 +38.2% | 19.4% | €6.12 | €3.59 | n/a | 4 |
| Nov ’24 | €2.77 | €4.81 +73.5% | 17.0% | €5.98 | €3.67 | €4.05 | 4 |
| Oct ’24 | €3.15 | €4.87 +54.5% | 17.4% | €5.90 | €3.62 | €4.26 | 4 |
| Sep ’24 | €3.39 | €4.87 +43.6% | 17.4% | €5.90 | €3.62 | €4.10 | 4 |
| Aug ’24 | €3.63 | €4.91 +35.5% | 20.3% | €6.06 | €3.37 | €4.13 | 4 |
| Jul ’24 | €3.68 | €4.94 +34.3% | 21.1% | €6.11 | €3.32 | €4.38 | 4 |
| Jun ’24 | €4.03 | €4.94 +22.6% | 21.1% | €6.11 | €3.32 | €4.65 | 4 |
| May ’24 | €3.46 | €4.87 +40.8% | 21.6% | €6.32 | €3.43 | €4.29 | 4 |
| Apr ’24 | €3.47 | €4.87 +40.2% | 21.6% | €6.32 | €3.43 | €4.95 | 4 |
| Mar ’24 | €3.74 | €4.87 +30.1% | 21.6% | €6.32 | €3.43 | €4.97 | 4 |
| Feb ’24 | €3.73 | €5.11 +37.3% | 12.5% | €6.09 | €4.55 | €4.28 | 4 |
| Jan ’24 | €3.52 | €5.11 +45.5% | 12.5% | €6.09 | €4.55 | €3.92 | 4 |
| Dec ’23 | €4.11 | €5.11 +24.6% | 12.5% | €6.09 | €4.55 | €3.45 | 4 |
| Nov ’23 | €4.54 | €7.05 +55.3% | 9.0% | €7.73 | €6.05 | €2.77 | 4 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Abercrombie & Fitch
US$7.2b
Through its subsidiaries, operates as an omnichannel retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally.
AFT
US$131.24
7D
-0.1%
1Y
94.3%
Luk Fook Holdings (International)
HK$8.7b
An investment holding company, engages in sourcing, designing, wholesaling, trademark licensing, and retailing various gold and platinum jewelry, and gem-set jewelry products.
LUY1
HK$1.75
7D
1.2%
1Y
-23.9%
Platform Group
€151.4m
Operates an online platform for premium and luxury fashion accessories in Germany, the Netherlands, Austria, the United Kingdom, Switzerland, France, Italy, and internationally.
FSNT
€7.48
7D
2.2%
1Y
37.0%